These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3701 related articles for article (PubMed ID: 30915065)

  • 1. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.
    Parada Venegas D; De la Fuente MK; Landskron G; González MJ; Quera R; Dijkstra G; Harmsen HJM; Faber KN; Hermoso MA
    Front Immunol; 2019; 10():277. PubMed ID: 30915065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice.
    Kim MH; Kang SG; Park JH; Yanagisawa M; Kim CH
    Gastroenterology; 2013 Aug; 145(2):396-406.e1-10. PubMed ID: 23665276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
    Gonçalves P; Araújo JR; Di Santo JP
    Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease.
    Russo E; Giudici F; Fiorindi C; Ficari F; Scaringi S; Amedei A
    Front Immunol; 2019; 10():2754. PubMed ID: 31824517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion.
    Jaworska K; Konop M; Bielinska K; Hutsch T; Dziekiewicz M; Banaszkiewicz A; Ufnal M
    Exp Physiol; 2019 Aug; 104(8):1226-1236. PubMed ID: 31243807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?
    Deleu S; Machiels K; Raes J; Verbeke K; Vermeire S
    EBioMedicine; 2021 Apr; 66():103293. PubMed ID: 33813134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
    Peng K; Xia S; Xiao S; Yu Q
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
    Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
    Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease.
    Zhuang X; Li T; Li M; Huang S; Qiu Y; Feng R; Zhang S; Chen M; Xiong L; Zeng Z
    Inflamm Bowel Dis; 2019 Oct; 25(11):1751-1763. PubMed ID: 31498864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of short-chain fatty acids in inflammatory bowel diseases and colorectal cancer].
    Włodarczyk J; Płoska M; Płoski K; Fichna J
    Postepy Biochem; 2021 Sep; 67(3):223-230. PubMed ID: 34894386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease.
    Ferrer-Picón E; Dotti I; Corraliza AM; Mayorgas A; Esteller M; Perales JC; Ricart E; Masamunt MC; Carrasco A; Tristán E; Esteve M; Salas A
    Inflamm Bowel Dis; 2020 Jan; 26(1):43-55. PubMed ID: 31211831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1α.
    Zhou C; Li L; Li T; Sun L; Yin J; Guan H; Wang L; Zhu H; Xu P; Fan X; Sheng B; Xiao W; Qiu Y; Yang H
    J Mol Med (Berl); 2020 Aug; 98(8):1189-1202. PubMed ID: 32696223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.
    Sivaprakasam S; Prasad PD; Singh N
    Pharmacol Ther; 2016 Aug; 164():144-51. PubMed ID: 27113407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A.
    Li YJ; Chen X; Kwan TK; Loh YW; Singer J; Liu Y; Ma J; Tan J; Macia L; Mackay CR; Chadban SJ; Wu H
    J Am Soc Nephrol; 2020 Jun; 31(6):1267-1281. PubMed ID: 32358041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyophilized fecal short-chain fatty acid and electrolyte determination by capillary electrophoresis with indirect UV detection for assessment of pediatric inflammatory bowel disease.
    Lemay JA; Yamamoto M; Kroezen Z; Shanmuganathan M; Ly R; Hart L; Pai N; Britz-McKibbin P
    J Pharm Biomed Anal; 2021 Jan; 192():113658. PubMed ID: 33091761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease.
    Yao Y; Liu Y; Xu Q; Mao L
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Sensing of Bacterial Metabolites in the Gut-kidney Axis.
    Foresto-Neto O; Ghirotto B; Câmara NOS
    Kidney360; 2021 Sep; 2(9):1501-1509. PubMed ID: 35373097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis.
    Yamada T; Hino S; Iijima H; Genda T; Aoki R; Nagata R; Han KH; Hirota M; Kinashi Y; Oguchi H; Suda W; Furusawa Y; Fujimura Y; Kunisawa J; Hattori M; Fukushima M; Morita T; Hase K
    EBioMedicine; 2019 Oct; 48():513-525. PubMed ID: 31521614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 186.